康诺亚生物医药科技有限公司（股票代码：02162）于2026年7月3日发布2026年6月股份变动月报表。公告显示，截至2026年6月30日，公司已发行普通股总数（不含库存股）维持在298,735,566股，未发生任何新增发行、购回或注销活动。
公司法定/注册股本保持在500,000,000股，面值每股0.0001美元，注册股本总额为50,000美元。报告期内并无库存股变动，也未出现可转换债券、股份期权或股权激励计划的变动。
公告同时确认，公司截至本月底已符合香港联交所关于公众持股量的相关规定。本次公告由执行董事Bo CHEN博士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.